Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide

PURPOSE: Darunavir, cobicistat, emtricitabine, and tenofovir alafenamide can be used as a single-tablet regimen (STR, DRV/c/FTC/TAF) or multiple-tablet regimen (MTR, DRV/c+FTC/TAF) to treat patients with human immunodeficiency virus (HIV). This study described treatment patterns and predictors of ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Chow, Wing, Donga, Prina, Côté-Sergent, Aurélie, Rossi, Carmine, Lefebvre, Patrick, Lafeuille, Marie-Hélène, Hardy, Hélène, Emond, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695894/
https://www.ncbi.nlm.nih.gov/pubmed/33262581
http://dx.doi.org/10.2147/PPA.S272211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695894/
https://www.ncbi.nlm.nih.gov/pubmed/33262581
http://dx.doi.org/10.2147/PPA.S272211

Ejemplares similares